Acasti Pharma | ACST - Ebitda





Ebitda Veränderung Datum
Acasti Pharma USD -3.01M 562K 2026-03
Addus HomeCare USD 44.51M 5.82M 2026-03
Amarin USD 12.54M 28.57M 2025-06
Cassava Sciences USD -11.73M 33.44M 2025-09
Knight Therapeutics CAD 24.45M 3.46M 2025-12
Option Care Health USD 104.77M 21.23M 2026-03
Organigram Holdings CAD -4.76M 10.02M 2026-03
Tilray USD 8.36M 1.82M 2025-09